isoxazoles has been researched along with Dermatitis, Atopic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, R; Briand, A; Cochet-Faivre, N; Hubinois, C; Prélaud, P | 1 |
| Andres, C; Belloni, B; Mempel, M; Ollert, M; Ring, J | 1 |
| Pfeiffer, C; Schmitt, J; Wozel, G | 1 |
| Enderlein, E; Homey, B; Lauceviciute, I; Ruzicka, T; Talhari, C | 1 |
| Asahina, A; Kagami, S; Kakinuma, T; Komine, M; Nakamura, K; Saeki, H; Sasaki, K; Tamaki, K; Tsunemi, Y | 1 |
| Barnetson, RS; Pua, VS | 1 |
| Pfeiffer, C; Vitéz, L; Wozel, G | 1 |
| Hsu, CJ; Wang, LF | 1 |
4 review(s) available for isoxazoles and Dermatitis, Atopic
| Article | Year |
|---|---|
Novel immunological approaches in the treatment of atopic eczema.
Topics: Adult; Antibodies, Monoclonal; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis, Atopic; Desensitization, Immunologic; Humans; Immunosuppressive Agents; Immunotherapy; Isoxazoles; Leflunomide; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
Recent developments in the treatment of adult atopic dermatitis.
Topics: Antibodies, Monoclonal; Calcineurin Inhibitors; Dermatitis, Atopic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-gamma; Isoxazoles; Keratolytic Agents; Leflunomide; Leukotriene Antagonists | 2006 |
Severe atopic dermatitis and leflunomide: first clinical experience and highlights of pertinent experimental data.
Topics: Adult; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Severity of Illness Index | 2006 |
Emerging treatment of atopic dermatitis.
Topics: Androstadienes; Animals; Dermatitis, Atopic; Desensitization, Immunologic; Fluticasone; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukotriene Antagonists; Mycophenolic Acid; T-Lymphocytes, Regulatory | 2007 |
4 other study(ies) available for isoxazoles and Dermatitis, Atopic
| Article | Year |
|---|---|
Open field study on the efficacy of fluralaner topical solution for long-term control of flea bite allergy dermatitis in client owned cats in Ile-de-France region.
Topics: Administration, Topical; Amoxicillin; Animals; Cat Diseases; Cats; Clavulanic Acid; Ctenocephalides; Dermatitis, Atopic; Female; Flea Infestations; France; Insecticides; Isoxazoles; Male; Prednisolone; Pruritus; Treatment Outcome | 2019 |
Leflunomide as a novel treatment option in severe atopic dermatitis.
Topics: Acute Disease; Adult; Dermatitis, Atopic; Drug Administration Schedule; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Time Factors; Treatment Outcome | 2004 |
COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions.
Topics: Cyclooxygenase Inhibitors; Dermatitis, Atopic; Drug Hypersensitivity; Humans; Isoxazoles; Male; Middle Aged; Skin Tests; Sulfonamides | 2005 |
Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.
Topics: Cell Line, Tumor; Cell Movement; Chemokine CCL26; Chemokines, CC; Culture Media, Conditioned; Dermatitis, Atopic; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Imidazoles; Interferon-gamma; Interleukin-13; Interleukin-4; Isoxazoles; Keratinocytes; Leflunomide; p38 Mitogen-Activated Protein Kinases; Protein Methyltransferases; Protein-Arginine N-Methyltransferases; Pyridines; Receptors, CCR3; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; Stimulation, Chemical; Tumor Necrosis Factor-alpha | 2005 |